Search clinical trials for: Ciclesonide nasal

Total 2479 results

Sunovion

Completed

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

Perennial Allergic Rhinitis

United States
Sunovion

Completed

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

Perennial Allergic Rhinitis | PAR

United States
AstraZeneca

Completed

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

Rhinitis, Allergic, Perennial | Hay Fever

United States
AstraZeneca

Completed

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Seasonal Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
Sunovion

Completed

Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis

Perennial Allergic Rhinitis

United States
Sunovion

Completed

A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler

Allergic Rhinitis (AR)

United Kingdom
Sunovion

Completed

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

Perennial Allergic Rhinitis

United States
Apotex Inc.

Completed

A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Sunovion

Completed

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis | PAR

United States
McGill University Health Centre/Research Institute...

Terminated

Inhaled Ciclesonide for Outpatients With COVID19 (CONTAIN)

COVID 19

Canada
University of Chicago
Sunovion

Withdrawn

A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray

Allergic Rhinitis

United States
Hamilton Health Sciences Corporation
Takeda; Kolding Sygehus

Completed

Effect of Ciclesonide on Exercise Induced Bronchoconstriction

Asthma

Canada
AstraZeneca

Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Rhinitis, Allergic, Perennial

United States
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Allergic Rhinitis | Perennial Allergic Rhinitis

United States
West Penn Allegheny Health System

Completed

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

Asthma | Allergic Rhinitis

United States
Allergy & Asthma Medical Group & Research Center

Completed

Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary

Asthma

United States
Handok Inc.
Takeda

Completed

Omnaris Versus Levocetirizine Phase 4 Study

Allergic Rhinitis

Korea, Republic of
Sanofi
Takeda

Completed

Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma

Asthma
Sanofi

Completed

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

Asthma

United States
Sanofi

Completed

Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.

Asthma

United States, Brazil, Poland, Russian Federation, Estonia, Mexico, Israel, Chile, Latvia, Puerto Rico, Costa Rica
AstraZeneca

Completed

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Rhinitis, Allergic, Seasonal

United States
Ola Blennow, MD, PhD
Karolinska University Hospital; Danderyd Hospital; Centrallasarettet Västerås

Active, not recruiting

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) (HALT)

Pneumonia, Viral | Covid-19 | Sars-CoV2

Sweden
AstraZeneca

Completed

Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia

Seasonal Allergic Rhinitis

Russian Federation
Sunovion

Completed

Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray

Perennial Allergic Rhinitis

United States
Sunovion

Completed

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Perennial Allergic Rhinitis

United States
Korea University Guro Hospital

Completed

A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19

COVID-19

Korea, Republic of
Sanofi
Takeda

Completed

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

Respiratory Tract Diseases | Asthma | Respiratory Hypersensitivity

France
Ophthalmic Consultants of Connecticut

Unknown

Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance

Dry Eye

United States
Zekai Tahir Burak Women's Health Research and Education...

Unknown

Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Transient Tachypnea of Newborn

Turkey
Imperial College London
Novartis Pharmaceuticals

Completed

Repeat Nasal Allergen Challenge

Hayfever

United Kingdom
University Hospital Ostrava
University of Ostrava

Recruiting

Nasal Obstruction Compared by Rhinomanometry and Nasal Inspiratory Peak Flow After Endoscopic Nasal Surgery

Nasal Obstruction | Pituitary Adenoma Invasive

Czechia
GlaxoSmithKline

Completed

Exploratory Subjective Sleep Study of a Prototype Nasal Dilator

Sleep Disorders | Congestion, Nasal

United States
Aardvark Medical Company

Completed

Home Usability of a Nasal Lavage System in Children

Sinusitis | Allergic Rhinitis | Nasal Congestion | Respiratory Tract Infection

United States
TC Erciyes University

Unknown

Comparison of Oxygenation Methods in Sedation

Deep Sedation

Turkey
Universitaire Ziekenhuizen KU Leuven

Unknown

Comparison Between 4 Different Nasal Dilators

Incompetence of Nasal Valve

Belgium
Radboud University Medical Center

Completed

Effects of Sublingual Immunotherapy on Grasspollen Allergy

Hayfever

Netherlands
Indonesia University

Not yet recruiting

Comparison Between Nasal Mask vs Nasal Prong on Pain Response in Neonate

Nasal Mask | Nasal Prong
Gelre Hospitals
Medisch Spectrum Twente

Recruiting

Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes (FIXIT)

Feeding Disorders | Feeding Tube Complication

Netherlands
University of Colorado, Denver
GlaxoSmithKline

Completed

Evaluation of Moderate to Severe Influenza Outcomes in Children (M2SFlu)

Fever | Influenza | Otitis Media | Lower Resp Tract Infection | Encephalitic Infection | Myositis Viral

United States
University of Aarhus
Spirare ApS

Completed

Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)

Rhinitis, Allergic, Seasonal

Denmark
Region Skane

Completed

Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief (OXYPAIN)

Angina

Sweden
Loma Linda University

Completed

External Nasal Dilator and Oxygen Therapy in Respiratory Failure (HFNC)

Acute Respiratory Failure

United States
VistaGen Therapeutics, Inc.

Recruiting

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) (PALISADE-3)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Completed

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge (Palisade-1)

Social Anxiety Disorder

United States
University of Maryland, Baltimore

Terminated

Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure

Heart Failure | Sleep Apnea

United States
Chang Gung University

Completed

High Flow Nasal Cannula on Exercise Endurance in COPD

COPD

Taiwan

3

Subscribe